Creative Medical Technology Holdings, Inc. (CELZ) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
Analysts estimate Earnings Per Share (EPS) of $-3.19 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.71 vs est $-3.19 (missed -16.3%). 2025: actual $-2.52 vs est $-2.04 (missed -23.5%). Analyst accuracy: 83%.
CELZ Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to Creative Medical Technology Holdings, Inc. in the past 3 months
EPS Estimates — CELZ
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.71
vs Est –$3.19
▼ 14.0% off
2025
Actual –$2.52
vs Est –$2.04
▼ 19.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — CELZ
61%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 27.3% off
2025
Actual $0.000B
vs Est $0.000B
▲ 50.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
